Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 85 Records) |
| Query Trace: Lung Neoplasms and ADC[original query] |
|---|
| Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients. Annals of diagnostic pathology 2020 9 49 151633. Wen Linfang, Wang Shenghao, Xu Weiran, Xu Xiaofeng, Li Mei, Zhang Yaqiong, Du Xiaobing, Liu Shua |
| Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations. Scientific reports 2020 8 10 (1): 13231. Kim Gahyun, Kim Jinho, Cha Hongui, Park Woong-Yang, Ahn Jin Seok, Ahn Myung-Ju, Park Keunchil, Park Yong-Jin, Choi Joon Young, Lee Kyung-Han, Lee Se-Hoon, Moon Seung Hw |
| Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma. Oncology letters 2020 Sep 20 (3): 2829-2839. Chen Xiaoyan, Lu Jun, Wu Yingying, Jiang Xingran, Gu Yajuan, Li Yunlong, Zhao Hongying, Jin Mul |
| Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib. Oncology letters 2020 Aug 20 (2): 1376-1382. Svaton Martin, Fiala Ondrej, Krakorova Gabriela, Blazek Jiri, Hurdalkova Karolina, Barinova Magda, Mukensnabl Petr, Pesek Mil |
| Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database. Lung cancer (Amsterdam, Netherlands) 2020 6 146 236-243. Kobayashi Keigo, Soejima Kenzo, Fukunaga Koichi, Shintani Yasushi, Sekine Ikuo, Shukuya Takehito, Takayama Koichi, Inoue Akira, Okamoto Isamu, Kiura Katsuyuki, Takahashi Kazuhisa, Yamamoto Nobuyuki, Takiguchi Yuichi, Miyaoka Etsuo, Okumura Meinoshin, Yoshino Ichiro, |
| Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer. Translational lung cancer research 2020 Apr 9 (2): 325-336. Hu Zhihuang, Zou Xuan, Qin Shanshan, Li Yuan, Wang Huijie, Yu Hui, Sun Si, Wu Xianghua, Wang Jialei, Chang Jianh |
| Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid-based cytology for lung cancer at bronchoscopic examinations. Diagnostic cytopathology 2020 3 48 (6): 516-523. Tanaka Ryota, Ohtsuka Kouki, Ogura Wataru, Arai Nobuaki, Yoshida Tsutomu, Nakazato Yoko, Tachibana Keisei, Takata Saori, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
| Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation. Pathology international 2020 Feb . Mito Remi, Matsubara Eri, Komohara Yoshihiro, Shinchi Yusuke, Sato Kensaku, Yoshii Daiki, Ohnishi Koji, Fujiwara Yukio, Tomita Yusuke, Ikeda Koei, Sakagami Takuro, Suzuki Mako |
| Molecular diagnosis and clinical outcome of a lung cancer patient with TP53-E285K mutated Li-Fraumeni syndrome harboring a somatic EGFR-KDD mutation. American journal of translational research 2020 11 12 (10): 6689-6693. Yang Dafu, Han Xue, Li Dan, Cui Saiqiong, Liu Sisi, Wu Xue, Dai Zhaox |
| Effect of ERCC2 rs13181 and rs1799793 polymorphisms and environmental factors on the prognosis of patients with lung cancer. American journal of translational research 2020 12 (10): 6941-6953. Zhang Haorui, Li Yutao, Guo Shicheng, Wang Yi, Wang Haijian, Lu Daru, Wang Jiucun, Jin Li, Jiang Gengxi, Wu Junjie, Han Yiping, Li Juho |
| A retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
| Value of radiomics model based on multi-parametric magnetic resonance imaging in predicting epidermal growth factor receptor mutation status in patients with lung adenocarcinoma. Journal of thoracic disease 2021 Jun 13 (6): 3497-3508. Wang Yuze, Wan Qi, Xia Xiaoying, Hu Jianfeng, Liao Yuting, Wang Peng, Peng Yu, Liu Hongyan, Li Xinch |
| Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients. Thoracic cancer 2021 Jun . Gong Lei, He Ronghui, Xu Yanjun, Luo Taobo, Jin Kaixiu, Yuan Wuzhou, Zheng Zengguang, Liu Lanxuan, Liang Zebin, Li Ao, Zheng Zhiguo, Li H |
| Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort. Pharmacogenomics and personalized medicine 2021 2 14 239-252. Machado-Rugolo Juliana, Gutierrez Prieto Tabatha, Fabro Alexandre Todorovic, Parra Cuentas Edwin Roger, Sá Vanessa Karen, Baldavira Camila Machado, Rainho Claudia Aparecida, Castelli Erick C, Farhat Cecilia, Takagaki Teresa Yae, Nagai Maria Aparecida, Capelozzi Vera Lui |
| Humoral immune response to epidermal growth factor receptor in lung cancer. Immunologic research 2021 1 69 (1): 71-80. Wang Yulin, Liu Fenghui, OuYang Songyun, Liu Man, Zhang Xue, Wang Peng, Zhao Chunling, Zhang Liguo, Dai Lipi |
| Association between F-FDG metabolic activity and programmed death ligand-1 (PD-L1) expression using 22C3 immunohistochemistry assays in non-small cell lung cancer (NSCLC) resection specimens. The British journal of radiology 2021 1 94 (1119): 20200397. Zhao Long, Liu Jinjun, Wang Huoqiang, Shi Jingy |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer. Journal of oncology 2022 4 2022 1763778. Li Yue, Li Chong, Jiang Ya, Han Xue, Liu Sisi, Xu Xiuxiu, Tang Wanxiangfu, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Xing Minyan, Zhang Yixiang, Wang Yuezh |
| Two Unusual Mutations in the Epidermal Growth Factor Receptor Gene in a Patient With Lung Adenocarcinoma. Cureus 2022 3 14 (2): e22372. Zapata Laguado Martin, Zuluaga Andrea, Parra Medina Rafael, Bruges Ricar |
| Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer. Translational cancer research 2022 2 8 (3): 736-751. Kuang Xiao, Xiao Jian, Dai Long-Xia, Zhang Li-Hai, He Bi-X |
| MRI features and whole-lesion apparent diffusion coefficient histogram analysis of brain metastasis from non-small cell lung cancer for differentiating epidermal growth factor receptor mutation status. Clinical radiology 2022 12 78 (3): e243-e250. Zheng Y, Huang W-J, Han N, Jiang Y-L, Ma L-Y, Zhang |
| Prediction of lung cancer risk in Chinese population with genetic-environment factor using extreme gradient boosting. Cancer medicine 2022 May . Li Yutao, Zou Zixiu, Gao Zhunyi, Wang Yi, Xiao Man, Xu Chang, Jiang Gengxi, Wang Haijian, Jin Li, Wang Jiucun, Wang Huai Zhou, Guo Shicheng, Wu Junj |
| Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data. Clinical lung cancer 2023 7 . Prashanth Ashok Kumar, Maryam Karimi, Alina Basnet, Lesley Seymour, Robert Kratzke, Elizabeth Brambilla, Thierry Le-Chevalier, Jean-Charles Soria, Ken André Olaussen, Siddhartha Devarakonda, Ramaswamy Govindan, Ming-Sound Tsao, Frances A Shepherd, Stefan Michiels, Stephen Grazia |
| Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
| Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2023 11 . Tian Gan, Wenting An, Yun Long, Jingting Wang, Hanfei Zhang, Meiyan Li |
| Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
| A spatio-temporal image analysis for growth of indeterminate pulmonary nodules detected by CT scan. Radiological physics and technology 2023 10 . Takaomi Hanaoka, Hisanori Matoba, Jun Nakayama, Shotaro Ono, Kayoko Ikegawa, Mitsuyo Oka |
| Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study. BMC pulmonary medicine 2024 4 24 (1): 167. Chao Mei, Tian Wang, Baoli Xu, Sanlan Wu, Xuelin Zhang, Yongning Lv, Yu Zhang, Zhaoqian Liu, Weijing Go |
| Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment. Frontiers in oncology 2024 1 13 1308313. Yongxia Chen, Mengye He, Zhengfeng Dai, Yina Wang, Jing Chen, Xiaoting Wang, Xiao Dong, Jianfei Huang, Jian Ruan, Xiaochen Zhang, Peng Shen, Yunlu J |
- Page last reviewed:Feb 1, 2024
- Content source: